Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials

Journal of Antimicrobial Chemotherapy

Volumn 49, Issue 6, 2002, Pages 999-1005

  Graffunder, Eileen M ^a   Venezia, Richard A ^a  

^a ALBANY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFSULODIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LEVOFLOXACIN; MACROLIDE; METICILLIN; METRONIDAZOLE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; SUCRALFATE; VANCOMYCIN; OFLOXACIN;

ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; ENTERIC FEEDING; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTIVARIATE ANALYSIS; RISK FACTOR; SURGERY; ADOLESCENT; ADULT; AGED; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CROSS INFECTION; DRUG EFFECT; MICROBIOLOGY; MIDDLE AGED; PENICILLIN RESISTANCE; PHYSIOLOGY; RETROSPECTIVE STUDY; RISK; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STATISTICAL MODEL; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; CROSS INFECTION; FEMALE; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MACROLIDES; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; ODDS RATIO; OFLOXACIN; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0035992140     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf009     Document Type: Article

References (47)

1. Methicillin-resistant Staphylococcus aureus: Implications for the 1990s and effective control measures
2. Antibiotic resistance in Gram positive bacteria: Epidemiological aspects
3. Antibiotic resistance. Control strategies
4. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991
5. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit
6. Methicillin-resistant S. aureus rates increase 260% in hospitals participating in HIP's international monitoring systems
7. True community-acquired methicillin-resistant Staphylococcus aureus bacteremia
8. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999
9. Methicillin-resistant Staphylococcus aureus in the community: A hospital-based study
10. Increase in community-acquired methicillin-resistant staphylococcus at a naval medical center
11. Editorial response: Community-acquired methicillin Staphylococcus aureus infections-where do we go from here?
12. Recommendations for the Control of Methicillin-Resistant Staphylococcus aureus (MRSA)
13. Control of methicillin-resistant Staphylococcus aureus in the hospital setting
14. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: Possible implications for control
15. Editorial response: A silver bullet for colonization and infection with methicillin-resistant Staphylococcus aureus still eludes us
16. Genesis of methicillin-resistant Staphylococcus aureus (MRSA). How treatment of MRSA infections has selected for vancomycin resistant Enterococcus faecium and the importance of antibiotic management and infection control
17. Antimicrobial-drug use and methicillin-resistant Staphylococcus aureus
18. Antibiotic usage and methicillin-resistant Staphylococcus aureus and analysis of causality
19. Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals
20. Methicillin-resistant Staphylococcus aureus in a teaching hospital: Investigation of nosocomial transmission using a matched case-control study
21. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides I: Clinical studies
22. A comparison of clinical virulence of nosocomially acquired methicillin resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital
23. Levofloxacin associated increase in methicillin-resistant Staphylococcus aureus infections
24. CDC definitions for nosocomial infections
25. Performance Standards for Antimicrobial Susceptibility Testing; Ninth Informational Supplement: Document M100-S9
26. Colonization and infection with methicillin-resistant Staphylococcus aureus: Associated factors and eradication
27. Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections
28. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus
29. Antibiotic resistant gram positive cocci: Implications for surgical practice
30. Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin
31. Decreased in vitro fluoroquinolone concentrations after admixture with an enteral feeding formulation
32. Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes
33. Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients
34. The bioavailability of nasogastric versus tablet form oral trovofloxacin in healthy subjects
35. Hospital acquired pneumonia: Methicillin resistance and intensive care unit admission
36. Risk factors for nosocomial bacteremia due to methicillin resistant Staphylococcus aureus
37. Analysis of nosocomial outbreaks with multiply and methicillin-resistant Staphylococcus aureus (MRSA) in Germany: Implications for hospital hygiene
38. The decline of methicillin resistance among Danish Staphylococcus aureus strains
39. Hospital-acquired infection with methicillin-resistant and methicillin-sensitive staphylococci
40. Trends in bacterial resistance to fluoroquinolones
41. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary
42. Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus
43. Quinolone resistance mediated by nor A: Physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome
44. Ciprofloxacin resistance in epidemic methicillin-resistant Staphylococcus aureus
45. Outbreaks of Staphylococcus aureus infections during treatment of late onset pneumonia with ciprofloxacin in a prospective, randomized study
46. The independent evolution of resistance to ciprofloxacin, rifampin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995)
47. Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure